By Gabe Friedman
Daily Journal Staff Writer
LOS ANGELES - CVS Pharmacy Inc. struck a $77.6 million agreement to ward off federal criminal charges for failing to adequately monitor the sale of pseudoephedrine - an over-the-counter cold medicine and a key ingredient in methamphetamine production.
As the largest pharmaceutical retailer in the United States, with more than $100 billion in annual revenues, CVS is unlikely to suffer...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In